The underlying mechanism can be elucidated through the work of Couto et al., who identified that the IL‐6/gp130/JAK pathway is responsible for the activation of the STAT3 pathway in a human thyroid cancer‐derived cell line [80]. The gene discussed is STAT3; the disease is thyroid gland carcinoma.